In this September 17, 2024 JACC issue, Dr. Zhi Jian Zhang and colleagues unveil a groundbreaking study on pulmonary arterial hypertension (PAH) that identifies plasma IgG fucosylation and glycan traits as promising prognostic markers. This research not only enhances survival predictions beyond current models but also opens intriguing possibilities for future therapeutic targets in PAH.
Informationen
- Sendung
- HäufigkeitTäglich
- Veröffentlicht9. September 2024 um 14:00 UTC
- Länge11 Min.
- BewertungUnbedenklich